{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:34:35Z","timestamp":1784194475314,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,15]]},"DOI":"10.1097\/tp.0b013e318264351e","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T19:05:16Z","timestamp":1344884716000},"page":"450-455","source":"Crossref","is-referenced-by-count":9,"title":["Conversion From Tacrolimus\/Mycophenolic Acid to Tacrolimus\/Leflunomide to Treat Cutaneous Warts in a Series of Four Pediatric Renal Allograft Recipients"],"prefix":"10.1097","volume":"94","author":[{"given":"Lieuko","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abanti","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldo","family":"Concepcion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1067\/mjd.2001.113465","article-title":". Skin diseases in children with organ transplants.","volume":"44","author":"Euvrard","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2133.2009.09297.x","article-title":". High viral load of human wart-associated papillomaviruses (PV) but not beta-PV in cutaneous warts independent of immunosuppression.","volume":"161","author":"Kohler","year":"2009","journal-title":"Br J Dermatol"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.jid.5700776","article-title":". Keratotic skin lesions and other risk factors are associated with skin cancer in organ- transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy.","volume":"127","author":"Bouwes Bavinck","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00467-009-1390-8","article-title":"Cutaneous warts in children before and after renal transplantation.","volume":"25","author":"Lunn","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1525-1470.1996.tb01247.x","article-title":"Treatment of molluscum contagiosum with oral cimetidine: clinical experience in 13 patients.","volume":"13","author":"Dohil","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000250949","article-title":". Warts in a pediatric renal transplant population.","volume":"155","author":"Ingelfinger","year":"1977","journal-title":"Dermatologica"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1749-6632.1993.tb17143.x","article-title":". Mechanisms of action of mycophenolic acid.","volume":"696","author":"Allison","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2230.2002.01150.x","article-title":"Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.","volume":"27","author":"Frieling","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1034\/j.1600-6143.2002.20909.x","article-title":". Prospective, pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction.","volume":"2","author":"Hardinger","year":"2002","journal-title":"Am J Transplant"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20452\/pamw.1131","article-title":". Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomised trials.","volume":"122","author":"Golicki","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2011.08.025","article-title":"Leflunomide in dermatology.","volume":"66","author":"Boyd","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R13-5-20210129","first-page":"1313","article-title":"Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.","volume":"11","author":"Palmer","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":". Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.","volume":"20","author":"Faguer","year":"2007","journal-title":"Transpl Int"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM200503173521125","article-title":". Leflunomide for polyomavirus type BK nephropathy.","volume":"352","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1345\/aph.1L180","article-title":"Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.","volume":"42","author":"Wu","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0952-7915(96)80090-2","article-title":"Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.","volume":"8","author":"Brazelton","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000053979","article-title":". Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.","volume":"42","author":"Waldman","year":"1999","journal-title":"Intervirology"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.TP.0000149338.97084.5F","article-title":". Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system.","volume":"79","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/TP.0b013e3182007be2","article-title":". Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection.","volume":"90","author":"Liacini","year":"2010","journal-title":"Transplantation"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1128\/JVI.01737-09","article-title":". Leflunomide inhibition of BK virus replication in renal tubular epithelial cells.","volume":"84","author":"Bernhoff","year":"2010","journal-title":"J Virol"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/TP.0b013e3181e94106","article-title":". Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.","volume":"90","author":"Avery","year":"2010","journal-title":"Transplantation"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3851\/IMP1763","article-title":"Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.","volume":"16","author":"Dunn","year":"2011","journal-title":"Antivir Ther"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00007890-200101150-00031","article-title":". Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide.","volume":"71","author":"Knight","year":"2001","journal-title":"Transplantation"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2466-9-22","article-title":"Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease.","volume":"9","author":"Witt","year":"2009","journal-title":"BMC Pulm Med"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1093\/ndt\/gfr416","article-title":". Leflunomide with low-dose everolimus for treatment of Kaposis sarcoma in a renal allograft recipient.","volume":"26","author":"Basu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.4049\/jimmunol.179.10.6479","article-title":". Leflunomide inhibits PDK1Akt pathway and induces apoptosis of human mast cells.","volume":"179","author":"Sawamukai","year":"2007","journal-title":"J Immunol"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-3046.2009.01183.x","article-title":". Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients.","volume":"14","author":"Araya","year":"2010","journal-title":"Pediatr Transplant"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/eci.11.20","article-title":"Leflunomide in renal transplantation.","volume":"7","author":"Chon","year":"2011","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201209150-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:13:05Z","timestamp":1743973985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201209150-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,15]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318264351e","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9,15]]}}}